ARTICLES BY JERRY MARTIN
-
![Continuous Manufacturing]( "Is Continuous Manufacturing Right For Your Drug Product?")
Is Continuous Manufacturing Right For Your Drug Product?5/30/2019Adapting any manufacturing process to continuous manufacturing requires in-depth chemical and mechanical engineering understanding as well as the right technologies.
-
![Big Data]( "Big Data And AI In Pharmaceutical Development & Manufacturing — An Inside Look")
Big Data And AI In Pharmaceutical Development & Manufacturing — An Inside Look2/27/2019Artificial intelligence and Big Data have the potential to lower the cost and time of drug trials, to better determine patient outcomes with established drugs, and to better design new drugs.
-
![PAC_2655]( "3D Printing In The Pharmaceutical Industry — Where Does It Currently Stand?")
3D Printing In The Pharmaceutical Industry — Where Does It Currently Stand?12/21/2018In 2015, Aprecia Pharmaceuticals produced the first tablet manufactured through 3D printing to be approved by the FDA. Now, with applications in controlled release, short-run medicines, and even the potential for on-site printing at pharmacies, 3D printing technology has the ability to transform the pharmaceutical industry.
-
![Packaging And Labeling]( "New Regulations And Safety Complicate Drug Labeling")
New Regulations And Safety Complicate Drug Labeling7/2/2018Multinational pharmaceutical companies have for decades manufactured drugs for global distribution. Nevertheless, the task of labeling is becoming increasingly difficult and time-consuming.
-
![State Of Serialization: Where FDA & The Pharma Industry Currently Stand]( "State Of Serialization: Where FDA & The Pharma Industry Currently Stand")
State Of Serialization: Where FDA & The Pharma Industry Currently Stand9/1/2017For the Drug Supply Chain Security Act to be effective, it requires pharma to institute electronic, interoperable systems that enable stakeholders to identify and trace drugs distributed into the U.S.
Jerry Martin
Jerry Martin is an independent consultant to pharmaceutical manufacturers and equipment suppliers for filtration, single use manufacturing, marketing, business development and regulatory compliance. He was previously senior VP, marketing and global scientific affairs for Pall Life Sciences, where he served the pharmaceutical, biotech, medical device, and vaccine industries for over 37 years. He is currently chairman emeritus of the Bio-Process Systems Alliance, the single-use manufacturing trade association, and a member of the USP Expert Panel on Plastic Systems Used for Manufacturing Pharmaceutical Products. He holds an M.Sc. in microbiology from the University of Toronto.